These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 35594607)

  • 1. Comparison of virus detection, productivity, and economic performance between lots of growing pigs vaccinated with two doses or one dose of PRRS MLV vaccine, under field conditions.
    Moura CAA; Philips R; Silva GS; Holtkamp DJ; Linhares DCL
    Prev Vet Med; 2022 Jul; 204():105669. PubMed ID: 35594607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of wild-type PRRSV detection patterns with mortality of MLV-vaccinated growing pig groups.
    Moura CAA; Philips R; Silva GS; Ramirez A; Gauger PC; Holtkamp DJ; Linhares DCL
    Prev Vet Med; 2021 Apr; 189():105270. PubMed ID: 33550121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
    Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
    Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.
    Charoenchanikran P; Kedkovid R; Sirisereewan C; Woonwong Y; Arunorat J; Sitthichareonchai P; Sopipan N; Jittimanee S; Kesdangsakonwut S; Thanawongnuwech R
    Trop Anim Health Prod; 2016 Oct; 48(7):1351-9. PubMed ID: 27315207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Description of changes of key performance indicators and PRRSV shedding over time in a naïve breeding herd following a PRRS MLV exposure.
    Trevisan G; Johnson C; Benjamin N; Bradner L; Linhares DCL
    Transbound Emerg Dis; 2021 Nov; 68(6):3230-3235. PubMed ID: 34553831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum and oral fluid antibody responses after vaccination with a modified live (MLV) porcine reproductive and respiratory syndrome virus (PPRSV) vaccine in PRRS endemic farms.
    Kuiek AM; Ooi PT; Yong CK; Ng CF
    Trop Anim Health Prod; 2015 Oct; 47(7):1337-42. PubMed ID: 26070293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vaccination route (intradermal vs. intramuscular) against porcine reproductive and respiratory syndrome using a modified live vaccine on systemic and mucosal immune response and virus transmission in pigs.
    Renson P; Mahé S; Andraud M; Le Dimna M; Paboeuf F; Rose N; Bourry O
    BMC Vet Res; 2024 Jan; 20(1):5. PubMed ID: 38172908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with a porcine reproductive and respiratory syndrome virus vaccine at 1-day-old improved growth performance of piglets under field conditions.
    Jeong J; Kim S; Park KH; Kang I; Park SJ; Yang S; Oh T; Chae C
    Vet Microbiol; 2018 Feb; 214():113-124. PubMed ID: 29408022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two commercially available porcine reproductive and respiratory syndrome virus (PRRSV) modified-live virus vaccines analyzing the growth performance in 1-day-old vaccinated swine located on endemic farms co-circulating PRRSV-1 and PRRSV-2.
    Yang S; Kang I; Jeong J; Oh T; Park KH; Park SJ; Ham HJ; Jin GR; Lee BH; Chae C
    J Vet Med Sci; 2020 Feb; 82(2):224-228. PubMed ID: 31866631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
    Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
    Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of viraemia and clinical signs after challenge with a heterologous PRRSV strain in PRRS Type 2 MLV vaccinated pigs: A challenge-dose study.
    Haiwick G; Hermann J; Roof M; Fergen B; Philips R; Patterson A
    PLoS One; 2018; 13(12):e0209784. PubMed ID: 30592764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
    Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
    Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
    Linhares DC; Cano JP; Wetzell T; Nerem J; Torremorell M; Dee SA
    Vaccine; 2012 Jan; 30(2):407-13. PubMed ID: 22063389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the efficacy of a porcine reproductive and respiratory syndrome subunit and a modified-live virus vaccine against respiratory diseases in endemic farms.
    Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Park SJ; Chae C
    Can J Vet Res; 2019 Apr; 83(2):110-121. PubMed ID: 31097873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection dynamics and incidence of wild-type porcine reproductive and respiratory syndrome virus in growing pig herds in the U.S. Midwest.
    Angulo J; Yang M; Rovira A; Davies PR; Torremorell M
    Prev Vet Med; 2023 Aug; 217():105976. PubMed ID: 37467679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
    Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D
    Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome associations with outcome following co-infection with porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) in pigs immunized with a PRRS modified live virus vaccine.
    Constance LA; Thissen JB; Jaing CJ; McLoughlin KS; Rowland RRR; Serão NVL; Cino-Ozuna AG; Niederwerder MC
    Vet Microbiol; 2021 Mar; 254():109018. PubMed ID: 33639341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy evaluation of three modified-live PRRS vaccines against a local strain of highly pathogenic porcine reproductive and respiratory syndrome virus.
    Huang Y; Li Z; Li J; Yibo-Kong ; Yang L; Mah CK; Liu G; Yu B; Wang K
    Vet Microbiol; 2019 Feb; 229():117-123. PubMed ID: 30642586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.